FMJ Facilities Management magazine providing industry-specific intelligence to FM and property professionals
Dalkia UK has been appointed by The Christie NHS Foundation Trust to deliver a new multi-service facilities contract.
Following a devastating fire in 2017, The Christie sought to rebuild the Patterson Building into a state of the art facility that will lead world-class transformational cancer research. Dalkia UK delivered a high quality mechanical and electrical engineering solution utilising innovative digital technology to challenge conventional construction.
Dalkia UK has subsequently been awarded a new contract to deliver technical facilities management services at the newly completed facility, including management of warranties and deployment of a new site based team.
At more than 25,000 sq. metres and 10 storeys high, Dalkia UK’s facilities team will now be responsible for a range of services including technical expertise and maintenance, reception and cleaning services. The on-site team will play a 24/7 critical role in delivering a first class service for Paterson’s building users, tenants, and stakeholders.
Nicolas Pages, Regional Operations Manager at Dalkia UK said of the contract award: “We are delighted to support this world-leading Cancer Research Centre for The Christie NHS Foundation Trust. It’s a privilege to work in such a collaborative environment, where individuals will receive leading-edge cancer treatments and benefit from the City of Manchester’s contribution to global medical innovation. This facility carries out research for the fight against cancer and I am confident our team will quickly become instrumental in supporting their critical activities.”
The Christie is the largest single site cancer centre in Europe. Treating more than 60,000 patients a year, it is the first accredited comprehensive cancer centre in the UK. The Paterson building is part of the Manchester Cancer Research Centre – a highly successful partnership between three powerhouses of innovation, The Christie, Cancer Research UK and The University of Manchester – and will be one of the top cancer research centres in the world.
